spacer
home > pmps > winter 2003 > why the health care industry needs a new approach to automated testing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Why the Health Care Industry Needs a New Approach to Automated Testing

Previous attempts to give automated testing a new approach have often disappointed for want of a coherent strategy: let's make sure the second generation of testing works better.

Neglect of effective automated testing could be costing businesses millions in lost sales, wasted time and missed opportunities. According to one model, failure to use automated testing appropriately can cost a health care company well over £200 million over the life of a single product. This estimate reflects misuse of highly trained staff, delayed launches and output levels that fall short of potential. Investing in the right automation programme at the right time could eliminate all this waste.

Why Automation is Imperative

The complexity and high standard of testing required in both R&D and manufacturing are such that, on paper at least, it seems clear that automation is now the only way to go. To understand the arguments, let us consider just one type of product: an inhaler. The testing requirements specified by regulatory authorities for an item like this include content uniformity, weight uniformity, emitted dose uniformity, bulk assay, fine particle fraction and impurities to name a few. Running all these tests manually eats up effort and lab space, and diverts analysts who have far better things to do with their time. Automating the tests not only frees up resources, but also increases speed, accuracy and consistency.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Adrian Howson, Managing Consultant in Health Care Process Development at PA Consulting Group

Adrian Howson is a Managing Consultant in Health care Process Development at PA Consulting Group. Since joining PA he has specified, built and implemented a number of automated processes for the manufacture and validated testing of pharmaceutical and medical products for many major organisations. He is a founding member of the UK Institute of Mechanical Engineer's Pharmaceutical Committee, a newly formed body that aims to promote the knowledge and application of mechanical engineering across the pharmaceutical industry.

spacer
Adrian Howson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Group Industry Awards 2019

PPMA Group is today issuing a ‘Final Call for Entries’ to the 2019 PPMA Group Industry Awards. All companies within the packaging and processing sector are invited to submit their FREE submission by the deadline of 17 July 2019.
More info >>

White Papers

Trial Timelines

Thomson Reuters

Save resources with accurate trial length projections. How analytics based on curated content can deliver insight for clinical strategies.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement